The Dow Jones and S&P 500 posted robust gains Friday afternoon. Nvidia led the Dow and Ulta topped the S&P 500 on the stock ...

Short sellers increased their bets against the broader healthcare sector in February vs. January, and Moderna remained the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The S&P 500 Index ( $SPX) ( SPY) Thursday closed down -1.39%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) closed down -1.30%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) closed down -1.89%. March ...

Mergers and acquisitions grabbed the spotlight in the biotech sector once again this week after Bristol Myers Squibb BMY ...

We recently compiled a list of the 12 Stocks Under $10 With High Upside Potential. In this article, we are going to take a look at where ImmunityBio, Inc. (NASDAQ:IBRX) stands against the other stocks ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

US Bancorp DE cut its position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 14.0% during the ...

Investment analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Cidara Therapeutics in a report issued on Monday, March 10th. HC Wainwright analyst E. Arce anticipates that the ...

The Dow Jones fell 270 points Tuesday after Monday's market sell-off. Nvidia, Palantir and Tesla rebounded on the stock ...

Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...